Literature DB >> 10712290

Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats.

C T Chen1, L L Hwang, J K Chang, N J Dun.   

Abstract

Orexin A and B, two recently isolated hypothalamic peptides, have been reported to increase food consumption upon intracerebroventricular injections in rats. In addition to the hypothalamus, orexin A-immunoreactive fibers have been observed in several areas of the medulla that are associated with cardiovascular functions. The present study was undertaken to evaluate the hypothesis that orexins may influence cardiovascular response by interacting with neurons in the medulla. Intracisternal injections of orexins A (0.0056-7.0 nmol) or B (0.028-0.28 nmol) dose dependently increased mean arterial pressure (MAP) by 4-27 mmHg and heart rate (HR) by 26-80 beats/min in urethan-anesthetized rats, with orexin A being more effective in this regard. MAP and HR were not changed by intravenous injection of orexins at higher concentrations. Microinjection of orexin A (14 pmol/50.6 nl) to the rostral ventrolateral medulla, which was confirmed by histological examination, increased MAP and HR. Our results indicate that, in addition to a role in positive feeding behavior, orexins may enhance cardiovascular response via an action on medullary neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712290     DOI: 10.1152/ajpregu.2000.278.3.R692

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  44 in total

1.  Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.

Authors:  Scott F Davis; Kevin W Williams; Weiye Xu; Nicholas R Glatzer; Bret N Smith
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

2.  Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex.

Authors:  Israt Z Shahid; Ahmed A Rahman; Paul M Pilowsky
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 4.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

5.  Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy.

Authors:  Yves Dauvilliers; Marie-Hélène Pennestri; Shirley Whittom; Paola A Lanfranchi; Jacques Y Montplaisir
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

6.  Intracisternal injection of orexin-A prevents ethanol-induced gastric mucosal damage in rats.

Authors:  Hiroto Yamada; Satoshi Tanno; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

Review 7.  The brain hypocretins and their receptors: mediators of allostatic arousal.

Authors:  Matthew E Carter; Jana Schaich Borg; Luis de Lecea
Journal:  Curr Opin Pharmacol       Date:  2009-02       Impact factor: 5.547

8.  Optogenetic identification of hypothalamic orexin neuron projections to paraventricular spinally projecting neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

9.  Direct projections from hypothalamic orexin neurons to brainstem cardiac vagal neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Neuroscience       Date:  2016-09-28       Impact factor: 3.590

Review 10.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.